Tagrid Eczema Cream Colloidal Oatmeal 1% Cream
NDC Package 85384-0024-1
Package Information
Tagrid Eczema Cream Colloidal Oatmeal 1% (colloidal oatmeal) cream is uses:USES: Helps relieve symptoms associated with eczema, including itching, redness, and irritation. This formulation utilizes a cream delivery system. Marketed by Tagrid Llc, this product is identified by NDC 85384-0024 and is authorized under FDA application M005.
Identification & Billing
- RxCUI: 240651 - colloidal oatmeal 1 % Topical Cream
- RxCUI: 240651 - colloidal oatmeal 10 MG/ML Topical Cream
- RxCUI: 240651 - Avena sativa 1 % Topical Cream
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Grain Proteins - [EXT]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 85384 - Tagrid Llc
- 85384-0024 - Tagrid Eczema Cream Colloidal Oatmeal 1%
- 85384-0024-1 - 56.7 g in 1 JAR
- 85384-0024 - Tagrid Eczema Cream Colloidal Oatmeal 1%
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85384-0024-1 identifies a specific commercial package of 56.7 g in 1 jar of Tagrid Eczema Cream Colloidal Oatmeal 1%, a human over the counter drug labeled by Tagrid Llc. This cream is formulated for topical use and contains oatmeal as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Tagrid Llc on May 15, 2026. The current certification is valid through December 31, 2027.
How is this Tagrid Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85384002401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.